论文部分内容阅读
AIM To develop a leptin peptide receptor antagonist linked to nanoparticles and determine its effect on viability of breast cancer cells.METHODS The leptin antagonist,LPrA2,was coupled via EDAC[1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide]to iron oxide n